Literature DB >> 29277893

DCLK1 promotes epithelial-mesenchymal transition via the PI3K/Akt/NF-κB pathway in colorectal cancer.

Weiying Liu1, Shixing Wang1, Qi Sun1, Zhen Yang1, Min Liu1, Hua Tang1.   

Abstract

Double cortin-like kinase 1 (DCLK1) plays important roles during the epithelial-mesenchymal transition (EMT) process in human colorectal cancer (CRC). However, the role of DCLK1 in regulating the EMT of CRC is still poorly understood. In this study, we report evidence that DCLK1 acts as a potent oncogene to drive its extremely malignant character of EMT in an NF-κB-dependent manner in CRC cells. Mechanistic investigations showed that DCLK1 induced the NF-κBp65 subunit expression through the PI3K/Akt/Sp1 axis and activated NF-κBp65 through the PI3K/Akt/IκBα pathway during the EMT of CRC cells. Moreover, we found that silencing the expression of DCLK1 inhibited the invasion and metastasis of CRC cells in vivo. Collectively, our findings identify DCLK1 as a pivotal regulator of an EMT axis in CRC, thus implicating DCLK1 as a potential therapeutic target for CRC metastasis.
© 2017 UICC.

Entities:  

Keywords:  NF-κB; PI3K/Akt pathway; colorectal cancer; double cortin-like kinase 1; epithelial-mesenchymal transition

Mesh:

Substances:

Year:  2018        PMID: 29277893     DOI: 10.1002/ijc.31232

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

2.  A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.

Authors:  Nuobei Zhang; Xin Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-05       Impact factor: 6.730

Review 3.  Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts.

Authors:  Zihong Wu; Bei Yin; Fengming You
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Alisol A attenuates malignant phenotypes of colorectal cancer cells by inactivating PI3K/Akt signaling.

Authors:  Weiwei Han; Wenjing Xing; Kechao Wang; Benjun Wang; Keyun Bai
Journal:  Oncol Lett       Date:  2022-06-07       Impact factor: 3.111

5.  Chemical Biology Toolkit for DCLK1 Reveals Connection to RNA Processing.

Authors:  Yan Liu; Fleur M Ferguson; Lianbo Li; Miljan Kuljanin; Caitlin E Mills; Kartik Subramanian; Wayne Harshbarger; Sudershan Gondi; Jinhua Wang; Peter K Sorger; Joseph D Mancias; Nathanael S Gray; Kenneth D Westover
Journal:  Cell Chem Biol       Date:  2020-08-04       Impact factor: 8.116

6.  Long noncoding RNA BMPR1B-AS1 facilitates endometrial cancer cell proliferation and metastasis by sponging miR-7-2-3p to modulate the DCLK1/Akt/NF-κB pathway.

Authors:  Tianjiao Lai; Haifeng Qiu; Lulu Si; Yu Zhen; Danxia Chu; Ruixia Guo
Journal:  Cell Cycle       Date:  2022-04-11       Impact factor: 5.173

7.  Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-κB/STAT3-regulated proteins.

Authors:  Yushan Yang; Lulu Ma; Yiming Xu; Yun Liu; Wenya Li; Jianchun Cai; Yiyao Zhang
Journal:  Cell Death Dis       Date:  2020-06-24       Impact factor: 8.469

8.  Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability.

Authors:  Yuxiong Lu; Junichi Maruyama; Keiko Kuwata; Hiroyuki Fukuda; Hiroaki Iwasa; Kyoko Arimoto-Matsuzaki; Haruhiko Sugimura; Yutaka Hata
Journal:  Biochem Biophys Rep       Date:  2018-10-30

Review 9.  A comprehensive look at the role of hyperlipidemia in promoting colorectal cancer liver metastasis.

Authors:  Yimin Shen; Caihua Wang; Yuezhong Ren; Jun Ye
Journal:  J Cancer       Date:  2018-07-30       Impact factor: 4.207

10.  DCLK1, a Putative Stem Cell Marker in Human Cholangiocarcinoma.

Authors:  Lorenzo Nevi; Sabina Di Matteo; Guido Carpino; Ilaria Grazia Zizzari; Safarikia Samira; Valeria Ambrosino; Daniele Costantini; Diletta Overi; Antonella Giancotti; Marco Monti; Daniela Bosco; Valerio De Peppo; Andrea Oddi; Agostino Maria De Rose; Maria Consiglia Bragazzi; Jessica Faccioli; Sara Massironi; Gian Luca Grazi; Pierluigi Benedetti Panici; Paquale Bartomeo Berloco; Felice Giuliante; Vincenzo Cardinale; Pietro Invernizzi; Giuseppina Caretti; Eugenio Gaudio; Domenico Alvaro
Journal:  Hepatology       Date:  2021-01       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.